Development of a Novel Intraocular-Pressure-Lowering Therapy Targeting ATX-Reference-Cited by-同舟云学术

Development of a Novel Intraocular-Pressure-Lowering Therapy Targeting ATX

Published:2019-11-01 Issue:11 Volume:42 Page:1926-1935
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Nagano Norimichi¹,Honjo Megumi¹,Kawaguchi Mitsuyasu²,Nishimasu Hiroshi³,Nureki Osamu³,Kano Kuniyuki⁴⁵,Aoki Junken⁴⁵,Komatsu Toru⁶,Okabe Takayoshi⁷,Kojima Hirotatsu⁷,Nagano Tetsuo⁷,Aihara Makoto¹

Affiliation:

1. Department of Ophthalmology, Graduate School of Medicine, The University of Tokyo

2. Graduate School of Pharmaceutical Sciences, Nagoya City University

3. Graduate School of Science, The University of Tokyo

4. Graduate School of Pharmaceutical Sciences, Tohoku University

5. Core Research for Evolutional Science and Technology (CREST)

6. Graduate School of Pharmaceutical Sciences, The University of Tokyo

7. Drug Discovery Initiative, The University of Tokyo

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/42/11/42_b19-00567/_pdf

Reference37 articles.

1. 1) Kaufman PL, Gabelt BT, Cynader M. Introductory comments on neuroprotection. Surv. Ophthalmol., 43 (Suppl. 1), S89–S90 (1999).

2. 2) Wiederholt M, Bielka S, Schweig F, Lutjen-Drecoll E, Lepple-Wienhues A. Regulation of outflow rate and resistance in the perfused anterior segment of the bovine eye. Exp. Eye Res., 61, 223–234 (1995).

3. 3) Gabelt BT, Kaufman PL. Changes in aqueous humor dynamics with age and glaucoma. Prog. Retin. Eye Res., 24, 612–637 (2005).

4. 4) Grant WM. Experimental aqueous perfusion in enucleated human eyes. Arch. Ophthalmol., 69, 783–801 (1963).

5. 5) Rosenquist R, Epstein D, Melamed S, Johnson M, Grant WM. Outflow resistance of enucleated human eyes at two different perfusion pressures and different extents of trabeculotomy. Curr. Eye Res., 8, 1233–1240 (1989).

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apoptosis inhibitor of macrophages/CD5L enhances phagocytosis in the trabecular meshwork cells and regulates ocular hypertension;Journal of Cellular Physiology;2023-08-16

2. Neuroaxonal and cellular damage/protection by prostanoid receptor ligands, fatty acid derivatives and associated enzyme inhibitors;Neural Regeneration Research;2023

3. Inflammatory and immunological aspects of glaucoma, optic neuritis, and neuromyelitis optica impacting eyesight;Translational Neuroimmunology, Volume 7;2023

4. Synthesis, Characterization, and in vivo Evaluation of a Novel Potent Autotaxin-Inhibitor;Frontiers in Pharmacology;2022-01-18

5. Various forms of glaucoma and their treatments;Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics;2022